Lv3
314 积分 2025-12-01 加入
Efficacy and Safety of Tegoprazan-Based Dual, Triple, and Quadruple Therapies in First-Line Helicobacter pylori Eradication: A Prospective Randomized Controlled Trial
2小时前
待确认
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline
1个月前
已完结
No significant association between Helicobacter pylori infection and Barrett’s esophagus: results from a large screening cohort in Central Europe
4个月前
已完结
Helicobacter pylori infection and risk of multiple sclerosis: An updated meta‐analysis
4个月前
已完结
Efficacy and Safety of Vonoprazan‐Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial
4个月前
已完结
Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis
4个月前
已完结
Effects of Successful Versus Delayed/Failed Helicobacter pylori Eradication Therapy on Subsequent Fracture Risk: a Population‐Based Cohort Study
5个月前
已完结
Tu1315 - Is the Interval Between the first and the Second H.P. Eradication Therapy Relevant for the Success of the Cure? A Comparison Between One Week, One Month and One Year
6个月前
已完结
Multidrug resistance inHelicobacter pylori: current state and future directions
7个月前
已完结
Comparison of Therapeutic Outcomes Between Concomitant Therapy and Tailored Therapy for Helicobacter pylori: A Multicenter, Prospective, and Randomized Study
8个月前
已完结
皖公网安备34019202002308
